FMP

FMP

Enter

CYTH - Cyclo Therapeutics, Inc.

Profile of Cyclo Therapeutics, Inc.(CYTH), Cyclo Therapeutics, Inc., a clinical stage biotechnology company, develops cyclodextrin-based produc

About

ceo

Mr. N. Scott Fine

sector

Healthcare

industry

Drug Manufacturers - Specialty & Generic

website

https://www.cyclotherapeutics.com

exchange

NASDAQ

Description

Cyclo Therapeutics, Inc., a clinical stage biotechnology company, develops cyclodextrin-based products for the treatment of various diseases. Its lead drug candidate is Trappsol Cyclo, an orphan drug, which is Phase III clinical trials for the treatment of Niemann-Pick Type C disease. The company also develops Trappsol Cyclo for the treatment of Alzheimer's disease. In addition, it sells cyclodextrins and related products to the pharmaceutical, nutritional, and other industries, primarily for use in diagnostics and specialty drugs. The company was formerly known as CTD Holdings, Inc. and changed its name to Cyclo Therapeutics, Inc. in September 2019. Cyclo Therapeutics, Inc. was incorporated in 1990 and is based in Gainesville, Florida.

CIK

0000922247

ISIN

US23254X2018

CUSIP

550241103

Address

6714 NW 16th Street

Phone

386 418 8060

Country

US

Employee

8

IPO Date

May 3, 2000

Key Executives

page loading card
FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedinfacebookinstagram
2017-2024 © Financial Modeling Prep